Purpose of the development: Designed for excretion of toxic substances and ballast endo-and exogenous nature, pathogenic microorganisms and viruses.

Recommended application field: Medicine and Pharmacology.

Advantages over analogues: "Siliks" does not have any competitors at a stop severe bleeding vital internal organs (kidney, liver, spleen, gastrointestinal tract) caused by ognectrelnymi injuries, surgery or accidents in transport. "Know-how".

The development stage readiness: Introduced in production

Description of the development:
()
"Siliks" - a synthetic amorphous, eco-friendly, harmless, with spherical particles with a non-porous silica developed specific surface (Ssp = 300-400 sq. m. / G). Physiological activity "Siliksa" due adsorbability to protein toxins, pathogens and viruses. Detoxicating effect (~ 90%) is reached very quickly (5 - 10 min.), The preparation does not require a preliminary diagnosis of infections can significantly reduce or eliminate the use of potent antibiotics and other medications which are usually toxic. "Siliks" is characterized by a large sorption capacity with respect to proteins (up to 800 mg / g), and microbes (10 [8] -10 [10] / g) adsorbing a wide range, a high adsorption rate. The special value of pharmaceuticals based on "Siliksa" lies in the fact that their use is indispensable in the aftermath of mass destruction population as a result of natural and man-made disasters. This includes first of all the first aid for wounds and injuries, elimination and prevention of gastrointestinal infections, viral hepatitis, disinfection and purification of drinking water. Promising is the use of "Siliksa" integrated programs aimed at the elimination of the long-term effects of the Chernobyl disaster in Ukraine, Russia, Belarus.

corresponds technical description
Conforms to technical characteristic

Possibility of transfer abroad:
Licence's sale
Licence's sale
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua